Circio shareholder vote set on board slate: Marron, Falck, Mellett, Burns, Sah

• Circio’s nomination committee is asking shareholders to elect Dinah Sah and Robert Burns to the board at an EGM on Aug. 25, 2026.
• Sah is a US RNA and gene-therapy veteran, formerly CSO at Voyager Therapeutics, previously VP of Research at Alnylam Pharmaceuticals.
• Burns, currently deputy director, has served on the board and R&D committee since 2010; the proposal would move him into a full director role.
• If elected, the five-person board would be Damian Marron (chair), Thomas Falck, Diane Mellett, Robert Burns, Dinah Sah.
• The nomination committee’s recommendation is to vote in favor of the proposed director elections.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Circio Holding ASA published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein.